HK-listed LongBio Pharma jumps on inclusion in Stock Connect programs
08/09/2026 04:02
BUZZ-HK-listed LongBio Pharma jumps on inclusion in Stock Connect programs ** Shares of LongBio Pharma (Suzhou) 1779.HK jump 8.4% to HK$124.4, on track for the biggest one-day pct gain since September 3
** Chinese allergic and autoimmune diseases focused biopharmaceuticals developer says it has been included in the list of eligible securities under each of Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs effective September 7
** The inclusion of the shares in the list of eligible securities will further expand the shareholder base and attract more long-term institutional investors, enhance trading liquidity of the shares - co
** Since debut on June 5, stock up 27.9% from the HK$96.06 offer price
** YTD, Hang Seng Biotech Index .HSBIO up 9.6%
(Reporting by Donny Kwok)
Recent news on LongBio Pharma (Suzhou)
See all newsHK-listed LongBio Pharma jumps on inclusion in Stock Connect programs
Brief: Longbio Pharma (Suzhou) Says NMPA Accepts BLA For Lp-003 For Seasonal Allergic Rhinitis
Brief: Longbio Pharma (Suzhou) Says FDA Approves Clinical Trial Application For LP-3 For Peanut Allergy
Brief: Longbio Pharma (Suzhou)Says Phase III Trial Of LP-3 For Seasonal Allergic Rhinitis Meets Primary Endpoints
LongBio Pharma shines in Hong Kong debut; Lung Fung, Dajin fall